United Therapeutics Corporation (UTHR) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 781.5M | 790.2M | 799.5M | 798.6M | 794.4M | 735.9M | 748.9M | 714.9M | 677.7M | 614.7M | 609.4M | 596.5M |
| Revenue Growth % | -1.62% | 7.38% | 6.76% | 11.71% | 17.22% | 19.72% | 22.89% | 19.85% | 33.7% | 25.07% | 18.1% | 27.76% |
| Cost of Goods Sold | 133.4M | 103.4M | 100.9M | 87.6M | 92.5M | 75.9M | 83.1M | 77.8M | 72.9M | 71M | 70.1M | 64.1M |
| COGS % of Revenue | 17.07% | 13.09% | 12.62% | 10.97% | 11.64% | 10.31% | 11.1% | 10.88% | 10.76% | 11.55% | 11.5% | 10.75% |
| Gross Profit | 648.1M | 686.8M | 698.6M | 711M | 701.9M | 660M | 665.8M | 637.1M | 604.8M | 543.7M | 539.3M | 532.4M |
| Gross Margin % | 82.93% | 86.91% | 87.38% | 89.03% | 88.36% | 89.69% | 88.9% | 89.12% | 89.24% | 88.45% | 88.5% | 89.25% |
| Gross Profit Growth % | -7.66% | 4.06% | 4.93% | 11.6% | 16.05% | 21.39% | 23.46% | 19.67% | 33.04% | 24.82% | 12.64% | 21.77% |
| Operating Expenses | 322.3M | 329.3M | 309.3M | 346.5M | 319.1M | 302.3M | 322.7M | 317.2M | 248.5M | 283.6M | 212.3M | 219M |
| OpEx % of Revenue | 41.24% | 41.67% | 38.69% | 43.39% | 40.17% | 41.08% | 43.09% | 44.37% | 36.67% | 46.14% | 34.84% | 36.71% |
| Selling, General & Admin | 184.1M | 189.8M | 181.8M | 190.8M | 170.1M | 162.5M | 219.2M | 177.6M | 144.4M | 132.2M | 127.6M | 130M |
| SG&A % of Revenue | 23.56% | 24.02% | 22.74% | 23.89% | 21.41% | 22.08% | 29.27% | 24.84% | 21.31% | 21.51% | 20.94% | 21.79% |
| Research & Development | 138.2M | 139.5M | 127.5M | 134M | 149M | 133.8M | 103.5M | 139.6M | 104.1M | 151.4M | 84.7M | 89M |
| R&D % of Revenue | 17.68% | 17.65% | 15.95% | 16.78% | 18.76% | 18.18% | 13.82% | 19.53% | 15.36% | 24.63% | 13.9% | 14.92% |
| Other Operating Expenses | 0 | 0 | 0 | 1000K | 0 | 1000K | 0 | 0 | 0 | 0 | 0 | -600K |
| Operating Income | 325.8M | 357.5M | 389.3M | 364.5M | 382.8M | 357.7M | 343.1M | 319.9M | 356.3M | 260.1M | 327M | 313.4M |
| Operating Margin % | 41.69% | 45.24% | 48.69% | 45.64% | 48.19% | 48.61% | 45.81% | 44.75% | 52.57% | 42.31% | 53.66% | 52.54% |
| Operating Income Growth % | -14.89% | -0.06% | 13.47% | 13.94% | 7.44% | 37.52% | 4.92% | 2.07% | 25.28% | 48.12% | 4.04% | 55.3% |
| EBITDA | 348.4M | 380.3M | 411.2M | 385.6M | 348.2M | 377.4M | 362.2M | 338.6M | 371.3M | 273.8M | 340.3M | 326.3M |
| EBITDA Margin % | 44.58% | 48.13% | 51.43% | 48.28% | 43.83% | 51.28% | 48.36% | 47.36% | 54.79% | 44.54% | 55.84% | 54.7% |
| EBITDA Growth % | 0.06% | 0.77% | 13.53% | 13.88% | -6.22% | 37.84% | 6.44% | 3.77% | 24.72% | 45.02% | 4% | 52.12% |
| D&A (Non-Cash Add-back) | 22.6M | 22.8M | 21.9M | 21.1M | -34.6M | 19.7M | 19.1M | 18.7M | 15M | 13.7M | 13.3M | 12.9M |
| EBIT | 325.8M | 447.1M | 441M | 415.7M | 417.4M | 404.4M | 398.7M | 319.9M | 411.9M | 310.5M | 327M | 313.4M |
| Net Interest Income | 38.8M | 40.1M | 43.4M | 44M | 45M | 41.4M | 39.7M | 34.6M | 40.5M | 35.9M | 29.7M | 22.4M |
| Interest Income | 41.8M | 43.2M | 46.4M | 51.3M | 51.1M | 49.3M | 49.8M | 46.2M | 53.8M | 51M | 45.3M | 37.2M |
| Interest Expense | 3M | 3.1M | 3M | 7.3M | 6.1M | 7.9M | 10.1M | 11.6M | 13.3M | 15.1M | 15.6M | 14.8M |
| Other Income/Expense | -7.5M | 86.5M | 48.7M | 43.9M | 40.7M | 38.8M | 45.5M | 35.4M | 42.3M | 35.3M | 24.8M | 21.8M |
| Pretax Income | 318.3M | 444M | 438M | 408.4M | 423.5M | 396.5M | 388.6M | 355.3M | 398.6M | 295.4M | 351.8M | 335.2M |
| Pretax Margin % | 40.73% | 56.19% | 54.78% | 51.14% | 53.31% | 53.88% | 51.89% | 49.7% | 58.82% | 48.06% | 57.73% | 56.19% |
| Income Tax | 43.4M | 79.7M | 99.3M | 98.9M | 101.3M | 95.2M | 79.5M | 77.2M | 92M | 78.3M | 84.2M | 76M |
| Effective Tax Rate % | 13.63% | 17.95% | 22.67% | 24.22% | 23.92% | 24.01% | 20.46% | 21.73% | 23.08% | 26.51% | 23.93% | 22.67% |
| Net Income | 274.9M | 364.3M | 338.7M | 309.5M | 322.2M | 301.3M | 309.1M | 278.1M | 306.6M | 217.1M | 267.6M | 259.2M |
| Net Margin % | 35.18% | 46.1% | 42.36% | 38.76% | 40.56% | 40.94% | 41.27% | 38.9% | 45.24% | 35.32% | 43.91% | 43.45% |
| Net Income Growth % | -14.68% | 20.91% | 9.58% | 11.29% | 5.09% | 38.78% | 15.51% | 7.29% | 27.27% | 64.35% | 11.83% | 123.45% |
| Net Income (Continuing) | 274.9M | 364.3M | 338.7M | 309.5M | 322.2M | 301.3M | 309.1M | 278.1M | 306.6M | 217.1M | 267.6M | 259.2M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 5.82 | 7.66 | 7.16 | 6.41 | 6.63 | 6.19 | 6.39 | 5.85 | 6.17 | 4.36 | 5.38 | 5.24 |
| EPS Growth % | -12.22% | 23.75% | 12.05% | 9.57% | 7.46% | 41.97% | 18.77% | 11.64% | 26.95% | 63.3% | 9.57% | 117.43% |
| EPS (Basic) | 6.32 | 8.36 | 7.73 | 6.86 | 7.18 | 6.74 | 6.93 | 6.26 | 6.52 | 4.62 | 5.71 | 5.53 |
| Diluted Shares Outstanding | 47.2M | 47.9M | 47.3M | 48.3M | 48.6M | 48.7M | 48.4M | 47.5M | 49.7M | 49.8M | 49.7M | 49.5M |
| Basic Shares Outstanding | 43.5M | 44.3M | 43.8M | 45.1M | 44.9M | 45.2M | 44.6M | 44.4M | 47M | 47M | 46.9M | 46.9M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |